<p>Robot-assisted radical cystectomy (RARC) is a complex procedure that requires patients to understand surgical indications, urinary diversion, perioperative treatment, complications, recovery, and long-term functional outcomes. Although artificial intelligence (AI) chatbots are increasingly used to obtain medical information, their suitability for RARC patient education remains unclear. We conducted a cross-sectional comparative evaluation of four contemporary AI chatbots: ChatGPT-5, DeepSeek-V4, Claude Sonnet 4.6, and Gemini 3.5 Pro. A set of 20 core patient-education questions on RARC was developed by three senior urologic experts. Chatbot responses were assessed using DISCERN, the Ensuring Quality Information for Patients tool, the Global Quality Scale, and JAMA benchmark criteria. Readability was evaluated using the Automated Readability Index, Coleman–Liau Index, Flesch–Kincaid Grade Level, Flesch Reading Ease, Gunning Fog Index, and SMOG. Reliability scores differed significantly across models for DISCERN, EQIP, and GQS, while JAMA benchmark criteria were summarized descriptively as transparency signals. DeepSeek-V4 achieved the highest mean scores for DISCERN, EQIP, and GQS, while ChatGPT-5 and DeepSeek-V4 showed the strongest JAMA benchmark performance. Gemini 3.5 Pro generally had the lowest reliability and transparency scores. Readability also varied across models. DeepSeek-V4 produced the most readable responses overall, whereas Gemini 3.5 Pro generated the most complex text. However, all models exceeded the recommended sixth-grade reading level, and FRES scores remained below the recommended threshold. Contemporary AI chatbots generated responses with variable presentation quality, transparency, and readability for common RARC patient-education questions. Because factual accuracy was not directly assessed, these tools should not be interpreted as validated sources of clinical guidance and should not replace individualized counseling by urologists.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Reliability and readability of AI chatbot responses to patient questions about robot-assisted radical cystectomy

  • Yang Liu,
  • Rongkang Li,
  • Peng Yu,
  • Yi Zhang,
  • Anguo Zhao,
  • Xi Xiao,
  • Zhilin Li,
  • Rui Liang,
  • Lei Peng,
  • Zhilong Dong

摘要

Robot-assisted radical cystectomy (RARC) is a complex procedure that requires patients to understand surgical indications, urinary diversion, perioperative treatment, complications, recovery, and long-term functional outcomes. Although artificial intelligence (AI) chatbots are increasingly used to obtain medical information, their suitability for RARC patient education remains unclear. We conducted a cross-sectional comparative evaluation of four contemporary AI chatbots: ChatGPT-5, DeepSeek-V4, Claude Sonnet 4.6, and Gemini 3.5 Pro. A set of 20 core patient-education questions on RARC was developed by three senior urologic experts. Chatbot responses were assessed using DISCERN, the Ensuring Quality Information for Patients tool, the Global Quality Scale, and JAMA benchmark criteria. Readability was evaluated using the Automated Readability Index, Coleman–Liau Index, Flesch–Kincaid Grade Level, Flesch Reading Ease, Gunning Fog Index, and SMOG. Reliability scores differed significantly across models for DISCERN, EQIP, and GQS, while JAMA benchmark criteria were summarized descriptively as transparency signals. DeepSeek-V4 achieved the highest mean scores for DISCERN, EQIP, and GQS, while ChatGPT-5 and DeepSeek-V4 showed the strongest JAMA benchmark performance. Gemini 3.5 Pro generally had the lowest reliability and transparency scores. Readability also varied across models. DeepSeek-V4 produced the most readable responses overall, whereas Gemini 3.5 Pro generated the most complex text. However, all models exceeded the recommended sixth-grade reading level, and FRES scores remained below the recommended threshold. Contemporary AI chatbots generated responses with variable presentation quality, transparency, and readability for common RARC patient-education questions. Because factual accuracy was not directly assessed, these tools should not be interpreted as validated sources of clinical guidance and should not replace individualized counseling by urologists.